JP2002515743A5 - - Google Patents

Download PDF

Info

Publication number
JP2002515743A5
JP2002515743A5 JP1997542431A JP54243197A JP2002515743A5 JP 2002515743 A5 JP2002515743 A5 JP 2002515743A5 JP 1997542431 A JP1997542431 A JP 1997542431A JP 54243197 A JP54243197 A JP 54243197A JP 2002515743 A5 JP2002515743 A5 JP 2002515743A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997542431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515743A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007726 external-priority patent/WO1997044356A2/en
Publication of JP2002515743A publication Critical patent/JP2002515743A/ja
Publication of JP2002515743A5 publication Critical patent/JP2002515743A5/ja
Pending legal-status Critical Current

Links

JP54243197A 1996-05-08 1997-05-07 神経増殖および腎臓増殖を刺激するためのRetリガンド(RetL) Pending JP2002515743A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US1742796P 1996-05-08 1996-05-08
US60/017,427 1996-05-08
US1930096P 1996-06-07 1996-06-07
US60/019,300 1996-06-07
US2185996P 1996-07-16 1996-07-16
US60/021,859 1996-07-16
PCT/US1997/007726 WO1997044356A2 (en) 1996-05-08 1997-05-07 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH

Publications (2)

Publication Number Publication Date
JP2002515743A JP2002515743A (ja) 2002-05-28
JP2002515743A5 true JP2002515743A5 (enExample) 2004-12-09

Family

ID=27360789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54243197A Pending JP2002515743A (ja) 1996-05-08 1997-05-07 神経増殖および腎臓増殖を刺激するためのRetリガンド(RetL)

Country Status (24)

Country Link
EP (2) EP1757617A1 (enExample)
JP (1) JP2002515743A (enExample)
KR (2) KR20060024843A (enExample)
CN (2) CN1163509C (enExample)
AT (1) ATE335003T1 (enExample)
AU (1) AU732392B2 (enExample)
BG (2) BG109433A (enExample)
BR (1) BR9710665A (enExample)
CA (1) CA2253871C (enExample)
CZ (1) CZ296516B6 (enExample)
DE (1) DE69736428T2 (enExample)
DK (1) DK0914339T3 (enExample)
EA (1) EA002544B1 (enExample)
EE (1) EE9800377A (enExample)
ES (1) ES2270465T3 (enExample)
IL (1) IL126918A (enExample)
IS (1) IS2361B (enExample)
NO (2) NO323612B1 (enExample)
NZ (1) NZ332706A (enExample)
PT (1) PT914339E (enExample)
RO (1) RO120343B1 (enExample)
SK (1) SK286115B6 (enExample)
TR (2) TR199802252T2 (enExample)
WO (1) WO1997044356A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696259B1 (en) 1995-11-13 2004-02-24 Licentia Ltd. Assays using glial cell line-derived neurotrophic factor receptors
EP0846764A3 (en) * 1996-11-27 1998-09-30 Smithkline Beecham Plc Glial cell line-derived neurotrophic factor alpha receptor family
WO1998024905A2 (en) * 1996-12-06 1998-06-11 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6372453B1 (en) 1997-02-18 2002-04-16 Genetech, Inc. Neurturin receptor
US6025157A (en) 1997-02-18 2000-02-15 Genentech, Inc. Neurturin receptor
US6777196B2 (en) 1997-02-18 2004-08-17 Genentech, Inc. Neurturin receptor
DE69832797T2 (de) * 1997-02-18 2006-08-17 Genentech, Inc., South San Francisco Neurturin-rezeptor
EP0983296A4 (en) * 1997-04-17 2002-11-06 Univ Washington RECEPTORS FOR TGF BETA RELATED NEUROTROPHIC FACTORS
WO1998053069A2 (en) * 1997-05-20 1998-11-26 Human Genome Sciences, Inc. Gdnf receptors
NZ501199A (en) * 1997-05-22 2001-12-21 Carlos F Glial cell line-derived neurotrophic factor receptors (BDNFR-beta)
JP2002505576A (ja) * 1997-05-30 2002-02-19 アムジエン・インコーポレーテツド 神経栄養因子レセプター
ATE320489T1 (de) * 1998-03-23 2006-04-15 Genentech Inc Gfr-alpha3 und seine verwendungen
US7026138B1 (en) 1998-03-23 2006-04-11 Genentech, Inc. Polynucleotides encoding GFRα3
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US20020055467A1 (en) 1998-07-06 2002-05-09 Johansen Teit E. Novel neurotrophic factors
WO2001016169A2 (en) * 1999-09-01 2001-03-08 Biogen, Inc. RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
ES2351215T3 (es) 2003-01-31 2011-02-01 Biogen Idec Ma Inc. Conjugados poliméricos de neublastina mutada.
HUE044025T2 (hu) 2010-05-20 2019-09-30 Array Biopharma Inc Makrociklusos vegyületek mint TRK-kináz inhibitorok
US10023855B2 (en) 2011-10-31 2018-07-17 Macrogen, Inc. Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker
WO2014017491A1 (ja) * 2012-07-26 2014-01-30 独立行政法人国立がん研究センター Cep55遺伝子とret遺伝子との融合遺伝子
EP2992331A4 (en) 2013-04-30 2017-03-29 Université de Montréal Novel biomarkers for acute myeloid leukemia
PL3322706T3 (pl) 2015-07-16 2021-07-19 Array Biopharma, Inc. Podstawione związki pirazolo[1,5-a]pirydynowe jako inhibitory kinazy ret
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
US11168090B2 (en) 2017-01-18 2021-11-09 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
TWI876442B (zh) 2017-10-10 2025-03-11 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
EP3740491A1 (en) 2018-01-18 2020-11-25 Array Biopharma, Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
EP3740486A1 (en) 2018-01-18 2020-11-25 Array Biopharma, Inc. Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
CA3087578C (en) 2018-01-18 2023-08-08 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors
WO2020055672A1 (en) 2018-09-10 2020-03-19 Array Biopharma Inc. Fused heterocyclic compounds as ret kinase inhibitors
US20240270855A1 (en) * 2021-06-03 2024-08-15 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Neuro-mesenchyme units control ilc2 and obesity via a brain-adipose circuit

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169637A (en) 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
CA1237671A (en) 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US4762915A (en) 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5185154A (en) 1989-02-02 1993-02-09 Liposome Technology, Inc. Method for instant preparation of a drug containing large unilamellar vesicles
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
JP3021800B2 (ja) 1990-07-24 2000-03-15 セイコーエプソン株式会社 半導体装置及びその製造方法
US5219990A (en) 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
FR2693107B1 (fr) 1992-07-01 1994-09-23 Chauvin Laboratoire Moyens pour la prévention de la cataracte secondaire.
AU1404395A (en) 1993-12-13 1995-07-03 Biogen, Inc. Anti-mullerian hormone receptor polypeptides and antibodies thereto
AU718979B2 (en) * 1995-11-13 2000-05-04 Urmas Arumae Glial cell line-derived neurotrophic factor receptors
DE69724241T2 (de) * 1996-03-14 2004-06-09 Genentech, Inc., South San Francisco Gdnf-rezeptor und dessen verwendung
US6455277B1 (en) * 1996-04-22 2002-09-24 Amgen Inc. Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000514474A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000501338A5 (enExample)
JP2000501825A5 (enExample)
JP2000511597A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000500912A5 (enExample)
JP2000505983A5 (enExample)
JP2000501876A5 (enExample)
JP2000506195A5 (enExample)
JP2002515743A5 (enExample)
JP2000505447A5 (enExample)
JP2000517075A5 (enExample)
JP2000501744A5 (enExample)
JP2000512992A5 (enExample)
JP2000501229A5 (enExample)
JP2000500857A5 (enExample)